Innovent Biologics Inc
01801: XHKG (HKG)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
HK$89.00 | Wyc | Tnwhdyqdy |
Innovent : Leader in China Biotech With Solid Commercial Potential
Business Strategy and Outlook
Innovent is a leading biotech company in China with strong roots in oncology, anchored by its core PD-1 drug Tyvyt. The price cut for PD-1 drugs has stabilized gradually. Hence, we expect stable revenue growth from Tyvyt in the next three years as Tyvyt has more indications approved.